tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NBIX Stock Latest News

Neurocrine Biosciences Earnings Call Highlights Growth Momentum
Company AnnouncementsNeurocrine Biosciences Earnings Call Highlights Growth Momentum
4d ago
NBIX
Neurocrine price target lowered to $177 from $180 at RBC Capital
PremiumThe Fly
Neurocrine price target lowered to $177 from $180 at RBC Capital
4d ago
NBIX
Neurocrine price target lowered to $185 from $187 at Needham
PremiumThe Fly
Neurocrine price target lowered to $185 from $187 at Needham
4d ago
NBIX
Neurocrine price target lowered to $190 from $195 at BofA
PremiumThe Fly
Neurocrine price target lowered to $190 from $195 at BofA
4d ago
NBIX
Neurocrine price target raised to $151 from $149 at Wedbush
PremiumThe Fly
Neurocrine price target raised to $151 from $149 at Wedbush
4d ago
NBIX
Neurocrine price target lowered to $173 from $175 at Morgan Stanley
PremiumThe FlyNeurocrine price target lowered to $173 from $175 at Morgan Stanley
4d ago
NBIX
Reaffirming Buy: Solid Core Franchise Execution and Underappreciated Pipeline Upside Support Mid-$150s Valuation
Premium
Ratings
Reaffirming Buy: Solid Core Franchise Execution and Underappreciated Pipeline Upside Support Mid-$150s Valuation
4d ago
NBIX
Neurocrine Biosciences: Durable Ingrezza Franchise and Emerging Crenessity Uptake Support Buy Rating and $190 Price Target
Premium
Ratings
Neurocrine Biosciences: Durable Ingrezza Franchise and Emerging Crenessity Uptake Support Buy Rating and $190 Price Target
4d ago
NBIX
Neurocrine price target raised to $204 from $203 at Citi
PremiumThe Fly
Neurocrine price target raised to $204 from $203 at Citi
4d ago
NBIX
Neurocrine price target lowered to $192 from $198 at H.C. Wainwright
PremiumThe Fly
Neurocrine price target lowered to $192 from $198 at H.C. Wainwright
4d ago
NBIX
Neurocrine Biosciences: Durable Ingrezza Growth and Emerging Crenessity Ramp Support Buy Rating Despite Near-Term Cost Pressures
PremiumRatings
Neurocrine Biosciences: Durable Ingrezza Growth and Emerging Crenessity Ramp Support Buy Rating Despite Near-Term Cost Pressures
4d ago
NBIX
Buy Rating on Pullback: Solid Top-Line Growth, Ingrezza Strength, and Crenessity Blockbuster Potential Support Long-Term Upside
PremiumRatings
Buy Rating on Pullback: Solid Top-Line Growth, Ingrezza Strength, and Crenessity Blockbuster Potential Support Long-Term Upside
4d ago
NBIX
Neurocrine Biosciences: Durable Franchise Momentum and Pipeline Investment Support Buy Rating
PremiumRatingsNeurocrine Biosciences: Durable Franchise Momentum and Pipeline Investment Support Buy Rating
5d ago
NBIX
Neurocrine reports Q4 adjusted EPS $1.88, consensus $2.30
Premium
The Fly
Neurocrine reports Q4 adjusted EPS $1.88, consensus $2.30
5d ago
NBIX
Neurocrine sees FY26 Ingrezza net product sales $2.7B-$2.8B
Premium
The Fly
Neurocrine sees FY26 Ingrezza net product sales $2.7B-$2.8B
5d ago
NBIX
NBIX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
NBIX Upcoming Earnings Report: What to Expect?
7d ago
NBIX
Neurocrine price target raised to $195 from $191 at BofA
PremiumThe Fly
Neurocrine price target raised to $195 from $191 at BofA
17d ago
NBIX
3 Best Stocks to Buy Today, 1/28/2026, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Today, 1/28/2026, According to Top Analysts
19d ago
IVA
NBIX
Neurocrine initiates Phase 2 study of NBI-1065890 in adults with TD
PremiumThe Fly
Neurocrine initiates Phase 2 study of NBI-1065890 in adults with TD
21d ago
NBIX
Neurocrine price target lowered to $178 from $188 at UBS
PremiumThe FlyNeurocrine price target lowered to $178 from $188 at UBS
24d ago
NBIX
Neurocrine’s Ingrezza capsules show efficacy in involuntary movement disorders
Premium
The Fly
Neurocrine’s Ingrezza capsules show efficacy in involuntary movement disorders
1M ago
NBIX
Neurocrine price target lowered to $177 from $179 at JPMorgan
Premium
The Fly
Neurocrine price target lowered to $177 from $179 at JPMorgan
1M ago
NBIX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >